文献速递中枢神经肿瘤放疗放疗物理与技术

脑转移瘤放射外科后症状性放射性坏死的个体风险可由V12Gy的连续函数预测

The individual risk of symptomatic radionecrosis after brain metastasis radiosurgery is predicted by a continuous function of the V12Gy.
PubMed 文献 · Clin Transl Radiat Oncol · 2021-01-14

该回顾性研究纳入128例患者共220个脑转移瘤病灶,分析立体定向放射外科(SRS)后症状性放射性坏死(RN)的个体风险预测模型。结果显示症状性RN风险可由V12Gy的连续函数预测(p=0.005),其他因素包括全脑放疗(WBRT)均无显著影响。

要点

  • 症状性RN风险与V12Gy呈连续函数关系(p=0.005)。
  • 既往或挽救性WBRT未增加症状性RN风险。
  • 其他因素如吸烟、糖尿病、术后SRS等均无显著影响。

核心结论

  • 症状性放射性坏死的个体风险可由基于V12Gy的连续函数模型预测,需前瞻性研究确认。

研究设计与样本

  • 回顾性分析CHU-UCL-Namur单中心接受SRS治疗≤3个实体瘤脑转移灶的患者数据。
  • 处方剂量15至24 Gy至70%等剂量线,根据病灶直径选择。
  • 随访MRI前18个月每3个月一次,之后每6个月一次。
  • 共分析128例患者220个病灶。

主要发现

  • 症状性RN风险由V12Gy的连续函数预测(p=0.005)。
  • 既往或挽救性WBRT未增加症状性RN风险。
  • 吸烟史、糖尿病、术后SRS、诊断特异性分级预后评估评分、脑叶位置及相对位置(浅表 vs 深部)均无显著影响。

关键数值与推荐

  • 症状性RN风险预测模型基于V12Gy连续函数(p=0.005)。
  • 处方剂量15至24 Gy至70%等剂量线,根据病灶直径选择。

临床怎么用

  • 可利用V12Gy连续函数个体化评估脑转移瘤SRS后症状性RN风险。
  • WBRT史不应作为排除SRS的理由,因其未增加症状性RN风险。

局限性

  • 回顾性研究设计,结论需前瞻性研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Brain metastases are frequently treated with stereotactic radiosurgery (SRS). Radionecrosis (RN) is the late side effect in up to 24% of patients, being symptomatic in 8-10%. Fixed values of the radiosurgical volume receiving 12 Gy or more (V12Gy) are used to roughly predict the global risk. The aim of this retrospective study is to fine-tune the model of individual risk prediction for symptomatic radionecrosis and identify modulating factors. MATERIALS AND METHODS: Data of patients treated with SRS for ≤3 BM of solid tumours at CHU-UCL-Namur were retrospectively reviewed. Doses ranging from 15 to 24 Gy were prescribed to the 70% isodose in function of the lesion diameter. Treatment was administered with a stereotactic linear accelerator. Follow-up magnetic resonance imaging was performed 3-monthly for 18 months and 6-monthly thereafter. RN was prospectively diagnosed and confirmed by the tumour board. V12Gy, previous or salvage whole-brain radiotherapy (WBRT), smoking history, diabetes, postoperative SRS, diagnosis-specific graded prognostic assessment score, cerebral lobe location and relative location (superficial versus deep) were retrieved. Univariate and multivariate analyses were performed to assess their predictive values and derive a model. RESULTS: 128 patients with 220 lesions were analysed. The risk of RN was predicted by a continuous function of the V12Gy (p = 0.005). No other factor had a significant impact, particularly WBRT that did not increase the risk. CONCLUSION: The risk of symptomatic RN is predicted on an individual basis by a model in function of the V12Gy and must be confirmed in a prospective study.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Daisne JF, De Ketelaere C, Jamart J, et al. The individual risk of symptomatic radionecrosis after brain metastasis radiosurgery is predicted by a continuous function of the V12Gy. Clin Transl Radiat Oncol. 2021. PMID: 33532633. doi:10.1016/j.ctro.2021.01.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。